Treating Hypercalcemia in Patients with Cancer
Hypercalcemia is one of the most common laboratory abnormalities in patients with cancer, and oncologists should know how to identify and treat it.
In The Clinic
Managing Anticoagulation in Patients with Brain Tumors
Patients with brain cancer are at increased risk of deep vein thrombosis and consequently pulmonary embolism.
Cardiotoxicity Associated With Monoclonal Antibody Chemotherapy
Surveillance for cardiotoxicity must be a part of treating patients with monoclonal antibodies.
Nonbacterial Thrombotic Endocarditis and Malignancy
Underlying malignancy is a potential cause of nonbacterial thrombotic endocarditis, understanding symptoms and treatment options is important.
MDRO Infections in Patients with Neutropenic Fever
Fever is a common symptom for patients with cancer who have neutropenia and it is often difficult to determine if they are in infectious in etiology.
Inpatient Versus Outpatient Cancer Therapy: Costs, Benefits, and Risks
Oncology clinicians must balance the cost, benefit, and risk when comparing inpatient versus outpatient care for patients.
Iniparib May Be Effective as Salvage Therapy for Metastatic Triple-Negative Breast Cancer
Despite promising results, iniparib was found to be ineffective as first-line therapy for patients with metastatic triple-negative breast cancer.
Rolapitant Proves Effective for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Rolapitant in combination with granisetron and dexamethasone is effective in preventing chemotherapy-induced nausea and vomiting.
Aprepitant for the Prevention of Chemotherapy-Induced Nausea, Vomiting in Multiple Myeloma
New regimen resulted in significantly less chemotherapy-induced nausea and vomiting in multiple myeloma patients.
Malignancies in Patients With Neurofibromatosis Type 1 (NF-1)
Patients with NF-1 are up to 4 times more likely to get both benign and malignant neoplasms, in the muscles, skin, and gastrointestinal tract.
Next post in General Oncology
